| About | Exhibitors | Speakers | Reviews | Deals |
HER2 is a promising multi-tumor target beyond breast cancer. Various therapies, including ADCs, multispecific antibodies, cell therapy, and radiopharmaceuticals, are showing great results. This event covers all challenges in HER2 treatment, from preclinical to post-approval indication-agnostic trials.
Listed In
Timings09:00 AM-06:00 PM (expected)Not Verified | Entry FeesCheck Official Website |
Estimated Turnout100 - 500 Delegates Based on previous editions | Event TypeConference |
EditionsOct 2023Frequency Not Available | Official LinksWebsiteContactsReport Error Claim this event |
Organizer Queries about the event?
Ask Organizer
| |
EditionOct 2023
How did you participate in this event?
Followers [ Users who have shown interest for this Event ] Join Community Invite
Add Profile
Invite users with similar interest
Kristin Wood
Global Events Specialist
Boston, United States
Ran Tian
mental health.counselor
Boston, United States
Bailey Carter
Student
Boston, United States
Jiang Xu
Postdoc
Boston, United States
Melissa Picceri Croad
CRNA
Boston, United States
kennethosawaru6
Graduate student
Boston, United States
Amani
Health & Wellness
Boston, United States
Gail Cipolla
Independent Affilliate
Boston, United StatesView More
Frequently Asked Questions Contact Organizer
Can I get a list of speakers participating in the event?
Can I get a list of exhibitors participating in the event?
Write a Review
Add Your Review42.367539-71.023157
Venue Map & Directions
1 Hotel Dr, Boston, MA 02128
USA
More Events in Boston
 Dec 162023 | International Conference on Civil and Architectural Engineering Boston, USA |
| Feb 242024 | PR Advanced Boston, USA |
| Mar 082024 | Child & AdolescentPsychopharmacology Boston, USA |
| Mar 242024 | Board Professionals Conference Boston, USA |
| Apr 152024 | Investment Conference Boston, USA |
Jan 182024
Dec 112023
